Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biglari Holdings (BH-A) Interest & Investment Income (2020 - 2025)

Biglari Holdings has reported Interest & Investment Income over the past 6 years, most recently at -$2.3 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at -$2.3 million for Q4 2025, up 32.04% from a year ago — trailing twelve months through Dec 2025 was $528000.0 (up 57.61% YoY), and the annual figure for FY2025 was $528000.0, up 57.61%.
  • Interest & Investment Income for Q4 2025 was -$2.3 million at Biglari Holdings, down from $1.5 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for BH-A hit a ceiling of $4.7 million in Q3 2024 and a floor of -$4.7 million in Q3 2023.
  • Median Interest & Investment Income over the past 5 years was $289000.0 (2022), compared with a mean of $304100.0.
  • Biggest five-year swings in Interest & Investment Income: soared 1516.89% in 2023 and later crashed 873.09% in 2024.
  • Biglari Holdings' Interest & Investment Income stood at -$64000.0 in 2021, then soared by 1335.94% to $791000.0 in 2022, then skyrocketed by 271.05% to $2.9 million in 2023, then tumbled by 215.47% to -$3.4 million in 2024, then soared by 32.04% to -$2.3 million in 2025.
  • The last three reported values for Interest & Investment Income were -$2.3 million (Q4 2025), $1.5 million (Q3 2025), and $2.9 million (Q2 2025) per Business Quant data.